Clinical Trials Insight: 700028283

Trial Profile

Clinical Trials Insight: 700028283

Phase of Trial: Phase I

Latest Information Update: 21 Mar 2011

At a glance

  • Drugs AR 9281 (Primary)
  • Indications Hypertension; Metabolic syndrome; Type 2 diabetes mellitus
  • Focus Adverse reactions; Biomarker; Pharmacokinetics
  • Sponsors Arete Therapeutics
  • Most Recent Events

    • 23 Dec 2008 Status changed from planning to completed, as reported in an Arete Therapeutics media release.
    • 18 Dec 2008 Results announced in an Arete Therapeutics media release.
    • 08 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top